Global PEGylated Proteins Market by Product (PEGylation Kits, PEGylation Reagents, Services), Protein Type (Colony-Stimulating Factor, Erythropoietin, Interferons), Indication, End-User - Forecast 2024-2030- Product Image

Sale

Global PEGylated Proteins Market by Product (PEGylation Kits, PEGylation Reagents, Services), Protein Type (Colony-Stimulating Factor, Erythropoietin, Interferons), Indication, End-User - Forecast 2024-2030

Report
194 Pages
March 2024
Region: Global
360iResearch™
ID: 5888972

UP TO €846EUR$875USD£725GBP OFF until Dec 31^st 2024

The PEGylated Proteins Market size was estimated at USD 1.43 billion in 2023, USD 1.57 billion in 2024, and is expected to grow at a CAGR of 10.14% to reach USD 2.81 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the PEGylated Proteins Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the PEGylated Proteins Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the PEGylated Proteins Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Aurigene Pharmaceutical Services Limited, Biogen Inc., BioMarin, Biomatrik Inc., Celares GmbH, Creative PEGWorks, Enzon Pharmaceuticals, Inc., Exelead, F. Hoffmann-La Roche Ltd., Horizon Therapeutics PLC, Iris Biotech GmbH, JenKem Technology USA Inc., Laysan Bio, Inc., Ligand Pharmaceuticals Inc, Merck KGaA, NOF CORPORATION, Novo Nordisk A/S, Pfizer Inc., Profacgen, Quanta BioDesign Ltd, QuiaPEG Pharmaceuticals Holding AB, Takeda Pharmaceuticals Company Limited, Thermo Fisher Scientific Inc., and UCB S.A.

Market Segmentation & Coverage

This research report categorizes the PEGylated Proteins Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- PEGylation Kits
- PEGylation Reagents
  - Biofunctional PEGs
  - Branched PEGs
  - Monofunctional Linear PEGs
  - Multi-Arm PEGs
- Services
Protein Type
- Colony-Stimulating Factor
- Erythropoietin
- Interferons
- mAbs
- Recombinant Factor VII
Indication
- Autoimmune Diseases
- Cancer
- Gastrointestinal Disorders
- Hemophilia
- Hepatitis
- Multiple Sclerosis
End-User
- Academic & Research Institutes
- CROs
- Pharmaceutical & Biopharmaceutical Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the PEGylated Proteins Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the PEGylated Proteins Market?
What are the technology trends and regulatory frameworks in the PEGylated Proteins Market?
What is the market share of the leading vendors in the PEGylated Proteins Market?
Which modes and strategic moves are suitable for entering the PEGylated Proteins Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. PEGylated Proteins Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic diseases among population
5.1.1.2. Growing investments in pharmaceutical research and development programs
5.1.1.3. Modernization of healthcare infrastructure across economies
5.1.2. Restraints
5.1.2.1. High costs associated with PEGylation process
5.1.3. Opportunities
5.1.3.1. Higher emphasis on biotechnology and biomolecular engineering
5.1.3.2. Potential of PEGylation in target specific drug delivery
5.1.4. Challenges
5.1.4.1. Time consuming stringent drug approval processes
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. PEGylated Proteins Market, by Product

6.1. Introduction
6.2. PEGylation Kits
6.3. PEGylation Reagents
6.4.1. Biofunctional PEGs
6.4.2. Branched PEGs
6.4.3. Monofunctional Linear PEGs
6.4.4. Multi-Arm PEGs
6.4. Services

7. PEGylated Proteins Market, by Protein Type

7.1. Introduction
7.2. Colony-Stimulating Factor
7.3. Erythropoietin
7.4. Interferons
7.5. mAbs
7.6. Recombinant Factor VII

8. PEGylated Proteins Market, by Indication

8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cancer
8.4. Gastrointestinal Disorders
8.5. Hemophilia
8.6. Hepatitis
8.7. Multiple Sclerosis

9. PEGylated Proteins Market, by End-User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. CROs
9.4. Pharmaceutical & Biopharmaceutical Companies

10. Americas PEGylated Proteins Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific PEGylated Proteins Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa PEGylated Proteins Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Abcam PLC
14.1.2. Aurigene Pharmaceutical Services Limited
14.1.3. Biogen Inc.
14.1.4. BioMarin
14.1.5. Biomatrik Inc.
14.1.6. Celares GmbH
14.1.7. Creative PEGWorks
14.1.8. Enzon Pharmaceuticals, Inc.
14.1.9. Exelead
14.1.10. F. Hoffmann-La Roche Ltd.
14.1.11. Horizon Therapeutics PLC
14.1.12. Iris Biotech GmbH
14.1.13. JenKem Technology USA Inc.
14.1.14. Laysan Bio, Inc.
14.1.15. Ligand Pharmaceuticals Inc
14.1.16. Merck KGaA
14.1.17. NOF CORPORATION
14.1.18. Novo Nordisk A/S
14.1.19. Pfizer Inc.
14.1.20. Profacgen
14.1.21. Quanta BioDesign Ltd
14.1.22. QuiaPEG Pharmaceuticals Holding AB
14.1.23. Takeda Pharmaceuticals Company Limited
14.1.24. Thermo Fisher Scientific Inc.
14.1.25. UCB S.A.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. PEGYLATED PROTEINS MARKET RESEARCH PROCESS
FIGURE 2. PEGYLATED PROTEINS MARKET SIZE, 2022 VS 2030
FIGURE 3. PEGYLATED PROTEINS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PEGYLATED PROTEINS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. PEGYLATED PROTEINS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. PEGYLATED PROTEINS MARKET DYNAMICS
FIGURE 7. PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2022 VS 2030 (%)
FIGURE 10. PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 12. PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 14. PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. PEGYLATED PROTEINS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. PEGYLATED PROTEINS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. PEGYLATED PROTEINS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. PEGYLATED PROTEINS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 9. PEGYLATED PROTEINS MARKET SIZE, BY BIOFUNCTIONAL PEGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PEGYLATED PROTEINS MARKET SIZE, BY BRANCHED PEGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PEGYLATED PROTEINS MARKET SIZE, BY MONOFUNCTIONAL LINEAR PEGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PEGYLATED PROTEINS MARKET SIZE, BY MULTI-ARM PEGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PEGYLATED PROTEINS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 15. PEGYLATED PROTEINS MARKET SIZE, BY COLONY-STIMULATING FACTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PEGYLATED PROTEINS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PEGYLATED PROTEINS MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PEGYLATED PROTEINS MARKET SIZE, BY MABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PEGYLATED PROTEINS MARKET SIZE, BY RECOMBINANT FACTOR VII, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 21. PEGYLATED PROTEINS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PEGYLATED PROTEINS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PEGYLATED PROTEINS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PEGYLATED PROTEINS MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. PEGYLATED PROTEINS MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. PEGYLATED PROTEINS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. PEGYLATED PROTEINS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. PEGYLATED PROTEINS MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. PEGYLATED PROTEINS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. CANADA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CANADA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 49. CANADA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 50. CANADA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 54. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. CHINA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. CHINA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 76. CHINA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 77. CHINA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. CHINA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. INDIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. INDIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 81. INDIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. INDIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 91. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 92. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 121. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 122. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 137. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 138. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 142. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 147. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 148. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 152. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 153. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 158. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. ITALY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. ITALY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 167. ITALY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 168. ITALY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. ITALY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 182. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 183. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. POLAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. POLAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 187. POLAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 188. POLAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. POLAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. QATAR PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. QATAR PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 192. QATAR PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 193. QATAR PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. QATAR PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 212. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 213. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. PEGYLATED PROTEINS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 241. PEGYLATED PROTEINS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 242. PEGYLATED PROTEINS MARKET LICENSE & PRICING

Companies Mentioned

Abcam PLC
Aurigene Pharmaceutical Services Limited
Biogen Inc.
BioMarin
Biomatrik Inc.
Celares GmbH
Creative PEGWorks
Enzon Pharmaceuticals, Inc.
Exelead
F. Hoffmann-La Roche Ltd.
Horizon Therapeutics PLC
Iris Biotech GmbH
JenKem Technology USA Inc.
Laysan Bio, Inc.
Ligand Pharmaceuticals Inc
Merck KGaA
NOF CORPORATION
Novo Nordisk A/S
Pfizer Inc.
Profacgen
Quanta BioDesign Ltd
QuiaPEG Pharmaceuticals Holding AB
Takeda Pharmaceuticals Company Limited
Thermo Fisher Scientific Inc.
UCB S.A.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	194
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.57 Billion
Forecasted Market Value ( USD ) by 2030	$ 2.81 Billion
Compound Annual Growth Rate	10.1%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,796GBP €3625EUR$3,749USD£3,107GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,542GBP €4593EUR$4,749USD£3,936GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,288GBP €5560EUR$5,749USD£4,765GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£5,034GBP €6527EUR$6,749USD£5,594GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,526GBP €8461EUR$8,749USD£7,251GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

PEGylated Proteins Market Report by Product, Protein Type, Application, End User, and Region 2024-2032

PEGylated Proteins - Global Strategic Business Report

Dendrimer-Based Nanotherapeutics

Frontiers in Clinical Drug Research - Hematology: Volume 5

Chitosan in Drug Delivery

About the PEGylated Protein Drug Market